These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


273 related items for PubMed ID: 6317839

  • 1. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors.
    Harden TK, Meeker RB, Martin MW.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):570-7. PubMed ID: 6317839
    [Abstract] [Full Text] [Related]

  • 2. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW, Smith MM, Harden TK.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [Abstract] [Full Text] [Related]

  • 3. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M, Waelbroeck M, Christophe J.
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [Abstract] [Full Text] [Related]

  • 4. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR, Wolfe BB.
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [Abstract] [Full Text] [Related]

  • 5. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
    Baker SP, Posner P.
    Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
    [Abstract] [Full Text] [Related]

  • 6. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
    Wang JX, Mei L, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203
    [Abstract] [Full Text] [Related]

  • 7. Evidence of paired M2 muscarinic receptors.
    Potter LT, Ballesteros LA, Bichajian LH, Ferrendelli CA, Fisher A, Hanchett HE, Zhang R.
    Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
    [Abstract] [Full Text] [Related]

  • 8. Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.
    Waelbroeck M, Robberecht P, Chatelain P, Christophe J.
    Mol Pharmacol; 1982 May; 21(3):581-8. PubMed ID: 7110116
    [Abstract] [Full Text] [Related]

  • 9. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA, Davis KH, Titeler M.
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [Abstract] [Full Text] [Related]

  • 10. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

  • 11. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
    De Léan A, Ong H, Gutkowska J, Schiller PW, McNicoll N.
    Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899
    [Abstract] [Full Text] [Related]

  • 12. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
    Zimmerman TW, Binder HJ.
    Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
    [Abstract] [Full Text] [Related]

  • 13. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [Abstract] [Full Text] [Related]

  • 14. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
    Hamblin MW, Ariani K, Adriaenssens PI, Ciaranello RD.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
    [Abstract] [Full Text] [Related]

  • 15. Muscarinic receptors of the vascular bed: radioligand binding studies on bovine splenic veins.
    Brunner F, Kukovetz WR.
    J Cardiovasc Pharmacol; 1986 Dec; 8(4):712-21. PubMed ID: 2427809
    [Abstract] [Full Text] [Related]

  • 16. High affinity binding of [3H]acetylcholine to muscarinic receptors. Regional distribution and modulation by guanine nucleotides.
    Gurwitz D, Kloog Y, Sokolovsky M.
    Mol Pharmacol; 1985 Sep; 28(3):297-305. PubMed ID: 4033630
    [Abstract] [Full Text] [Related]

  • 17. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR, Wolfe BB.
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [Abstract] [Full Text] [Related]

  • 18. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V, McNeill JR, Sulakhe PV, Triggle CR.
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [Abstract] [Full Text] [Related]

  • 19. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J, Brown JH.
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [Abstract] [Full Text] [Related]

  • 20. Presence of m3 subtype muscarinic acetylcholine receptors and receptor-mediated increases in the cytoplasmic concentration of Ca2+ in Jurkat, a human leukemic helper T lymphocyte line.
    Kaneda T, Kitamura Y, Nomura Y.
    Mol Pharmacol; 1993 Mar; 43(3):356-64. PubMed ID: 8383801
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.